A nomogram model to predict death rate among non-small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) database

Bo Jia,Qiwen Zheng,Jingjing Wang,Hongyan Sun,Jun Zhao,Meina Wu,Tongtong An,Yuyan Wang,Minglei Zhuo,Jianjie Li,Xue Yang,Jia Zhong,Hanxiao Chen,Yujia Chi,Xiaoyu Zhai,Ziping Wang
DOI: https://doi.org/10.1186/s12885-020-07147-y
IF: 4.638
2020-07-17
BMC Cancer
Abstract:Abstract Background This study aimed to establish a novel nomogram prognostic model to predict death probability for non-small cell lung cancer (NSCLC) patients who received surgery.. Methods We collected data from the Surveillance, Epidemiology, and End Results (SEER) database of the National Cancer Institute in the United States. A nomogram prognostic model was constructed to predict mortality of NSCLC patients who received surgery. Results A total of 44,880 NSCLC patients who received surgery from 2004 to 2014 were included in this study. Gender, ethnicity, tumor anatomic sites, histologic subtype, tumor differentiation, clinical stage, tumor size, tumor extent, lymph node stage, examined lymph node, positive lymph node, type of surgery showed significant associations with lung cancer related death rate ( P < 0.001). Patients who received chemotherapy and radiotherapy had significant higher lung cancer related death rate but were associated with significant lower non-cancer related mortality (P<0.001). A nomogram model was established based on multivariate models of training data set. In the validation cohort, the unadjusted C-index was 0.73 (95% CI, 0.72–0.74), 0.71 (95% CI, 0.66–0.75) and 0.69 (95% CI, 0.68–0.70) for lung cancer related death, other cancer related death and non-cancer related death. Conclusions A prognostic nomogram model was constructed to give information about the risk of death for NSCLC patients who received surgery.
oncology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to establish a new nomogram prognostic model to predict the mortality rate of non - small - cell lung cancer (NSCLC) patients who receive surgical treatment. Specifically, the study aims to construct a model that can predict the probability of death due to lung cancer, other cancers, and non - cancer causes in NSCLC patients by using a large amount of data in the Surveillance, Epidemiology, and End Results (SEER) database of the National Cancer Institute in the United States. This helps to better evaluate the prognosis of NSCLC patients who receive surgical treatment and provide better treatment strategies for these patients. The research background indicates that the incidence and mortality of lung cancer rank first in China and globally, and non - small - cell lung cancer (NSCLC) accounts for approximately 75% to 80% of all lung cancer patients. Therefore, the treatment of NSCLC has become an urgent public health problem. Although patients in the early stage and some locally advanced NSCLC patients need radical surgery, the postoperative survival situation varies greatly, and many factors affecting prognosis, such as age, tumor size, number of metastatic lymph nodes, and clinical stage, have been reported in multiple studies. However, there are still controversies regarding the influence of factors such as race, surgical method, location of the primary tumor, anatomical site, and histological subtype on prognosis. In addition, previous studies mainly focused on investigating prognostic factors related to lung - cancer - related death, and few studies considered non - cancer - related death. Therefore, this study uses population data in the SEER database to estimate lung - cancer - related, other - cancer - related, and non - cancer - related causes of death through innovative and validated nomogram models, in order to provide more comprehensive prognostic information for NSCLC patients who receive surgical treatment.